If it doesn't sound, it's already a hit
A doubling investment target that is suitable for both short and medium-term - Kanghua Biology
Concept: One of the few rabies vaccine public companies
Growth: The company's operating results from 2017 to 2020, the compound growth rate is more than 50%, is currently in the growth stage, the three quarters reported net profit increased by 69%, the dynamic price-earnings ratio is only 25 times, for the growth of stocks with a price-earnings ratio of hundreds of times, it is not cheap.
Technically: after listing, it fell all the way from the highest 996 yuan to 156 yuan and began to rebound, and after a wave of rebound to 264 yuan, it is now a two-wave correction, looking forward to the three waves of the main rise
Operation guide: Keep an eye on the 5-day line and observe the bottom split K-line pattern, stand on the 5-day line, enter the market, and leave the market after falling below the 5-day line again. Of course, there is a bottom type, the bottom signal is more clear, and the entry is more secure. The amount of energy is also an important technical indicator of whether to adjust in place, in recent days, Kanghua bio-shrinkage is obvious, combined with whether it can stand on the 5-day line, the odds are one point more.
The stock market is risky and investments need to be cautious
Pay attention, don't get lost, like, get rich!
